+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Peanut Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768073
  • Report
  • April 2019
  • Region: Global
  • 93 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Aimmune Therapeutics Inc
  • Allergy Therapeutics Plc
  • AnaptysBio Inc
  • DBV Technologies SA
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
The global clinical trial report- “2019 Peanut Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Peanut Allergy. It presents in-depth analysis of Peanut Allergy clinical trials across markets and companies. The research work is for providing complete understanding into trends in Peanut Allergy.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Peanut Allergy clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Peanut Allergy

The research work is prepared through extensive and continuous research on Peanut Allergy trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Peanut Allergy patients are identified
  • The report includes panorama of Peanut Allergy clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Peanut Allergy clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aimmune Therapeutics Inc
  • Allergy Therapeutics Plc
  • AnaptysBio Inc
  • DBV Technologies SA
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Peanut Allergy Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Peanut Allergy Clinical Trials by Region
2.2.2 Average Enrollment of Peanut Allergy Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Peanut Allergy Treatment, 2019

3. Region wise Peanut Allergy Clinical Trials
3.1 Asia Pacific Peanut Allergy Clinical Trials by Country
3.2 Europe Peanut Allergy Clinical Trials by Country
3.3 North America Peanut Allergy Clinical Trials by Country
3.4 Middle East and Africa Peanut Allergy Clinical Trials by Country
3.5 South and Central America Peanut Allergy Clinical Trials by Country

4. Peanut Allergy Clinical Trial Trends
4.1 Start Year wise Peanut Allergy Clinical Trials
4.2 Phase wise Peanut Allergy Clinical Trials
4.3 Trial Status wise Peanut Allergy Clinical Trials
4.4 Trial Type wise Peanut Allergy Clinical Trials

5. Peanut Allergy Average Enrollment Trends
5.1 Average Enrollment in Peanut Allergy Trials by Year
5.2 Average Enrollment in Peanut Allergy Trials by Phase
5.3 Average Enrollment in Peanut Allergy Trials by Status
5.4 Average Enrollment in Peanut Allergy Trials by Type of Trial

6. Companies Participating in Peanut Allergy Clinical Trials
6.1 Peanut Allergy Trials by Sponsor Type
6.2 Peanut Allergy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Peanut Allergy Trials- Phase 1
7.2 Peanut Allergy Trials- Phase 2
7.3 Peanut Allergy Trials- Phase 3
7.4 Peanut Allergy Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Peanut Allergy Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Peanut Allergy Clinical Trials and Enrolment
Figure 5: Europe - Country wise Peanut Allergy Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Peanut Allergy Clinical Trials and Enrolment
Figure 7: North America - Country wise Peanut Allergy Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Peanut Allergy Clinical Trials and Enrolment
Figure 9: Peanut Allergy Clinical Trials by Phase
Figure 10: Peanut Allergy Clinical Trials by Trial Status
Figure 11: Peanut Allergy Clinical Trials by Type
Figure 12: Peanut Allergy Clinical Trials by Sponsor Type
Figure 13: Peanut Allergy Clinical Trials by Leading Sponsors
Figure 14: Peanut Allergy Average Enrollment by Phase
Figure 15: Peanut Allergy Average Enrollment by Trial Status
Figure 16: Peanut Allergy Average Enrollment by Type
Figure 17: Peanut Allergy- Average Enrolment by Type of Sponsors
Figure 18: Peanut Allergy- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Peanut Allergy Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Peanut Allergy Clinical Trials and Enrolment
Table 5: Europe - Country wise Peanut Allergy Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Peanut Allergy Clinical Trials and Enrolment
Table 7: North America - Country wise Peanut Allergy Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Peanut Allergy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Peanut Allergy Average Enrollment by Phase
Table 15: Peanut Allergy Average Enrollment by Trial Status
Table 16: Peanut Allergy Average Enrollment by Type
Table 17: Peanut Allergy- Average Enrolment by Type of Sponsors
Table 18: Peanut Allergy- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aimmune Therapeutics Inc
  • Allergy Therapeutics Plc
  • Allertein Therapeutics LLC
  • AnaptysBio Inc
  • DBV Technologies SA
  • Droege International Group AG
  • F. Hoffmann-La Roche Ltd
  • Food Allergy Research & Education Inc
  • Novartis AG
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll